Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > NKTR Nektar Therapeutics > Detailed Quotes

NKTR Nektar Therapeutics

3.200
+0.160+5.26%
Close 09/30 16:00 ET
3.2000.0000.00%
Post Mkt Price 09/30 16:07 ET
High
3.360
Open
3.060
Turnover
6.94M
Low
3.055
Pre Close
3.040
Volume
2.15M
Market Cap
596.08M
P/E(TTM)
Loss
52wk High
18.690
Shares
186.27M
P/E(Static)
Loss
52wk Low
2.960
Float Cap
566.75M
Bid/Ask %
-33.33%
Historical High
111.360
Shs Float
177.11M
Volume Ratio
1.23
Historical Low
2.450
Dividend TTM
--
Div Yield TTM
--
P/B
1.30
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
1.21%
Amplitude
10.03%
Avg Price
3.226
Lot Size
1
Float Cap
566.75M
Bid/Ask %
-33.33%
Historical High
111.360
Shs Float
177.11M
Volume Ratio
1.23
Historical Low
2.450
Dividend TTM
--
P/B
1.30
Dividend LFY
--
Turnover Ratio
1.21%
Amplitude
10.03%
Avg Price
3.226
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Nektar Therapeutics is a research-based biopharmaceutical company which engages in discovering and developing medicines in areas of unmet medical need. Its research and development pipeline of new investigational drugs includes therapies for oncology, immunology and virology. The firm focuses on using new chemistry approaches to make medicines to treat cancer and autoimmune diseases. The company was founded in 1990 and is headquartered in San Francisco, CA.
CEO: Mr. Howard W. Robin
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...